title: Roundtable discussion: Part I--Epidemiologic, demographic, and treatment challenges in hypertension.
abstract: Hypertension is one of the most pervasive medical disorders in this country. As the nation's population ages, the number of patients with hypertension can be expected to rise substantially. On December 9, 1999, a panel of managed care medical directors, pharmacy directors, clinicians, and health economists convened in Irvine, Texas to discuss aspects of hypertension management and economic analysis. This roundtable is presented in three parts, including (1) a summary of the challenges of hypertension management from the point of view of the clinician, (2) the introduction of a pharmacoeconomic model of hypertension management, and (3) a discussion of how health plans approach this insidious disorder.
authors.forename: P
authors.initials: P
authors.lastname: Penna
authors.forename: E
authors.initials: E
authors.lastname: Cox
authors.forename: T
authors.initials: T
authors.lastname: Joseph
authors.forename: L
authors.initials: L
authors.lastname: Lehman
authors.forename: T
authors.initials: T
authors.lastname: Morrow
authors.forename: A
authors.initials: A
authors.lastname: Richter
authors.forename: J
authors.initials: J
authors.lastname: Sowers
authors.forename: D
authors.initials: D
authors.lastname: Tepper
mesh_terms: D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D003710:Demography; D017850:Economics, Pharmaceutical; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology*; D008019:Life Style; D008875:Middle Aged; D015995:Prevalence; D012307:Risk Factors; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
chemical_list: D000959:Antihypertensive Agents